A recent non-peer-reviewed study based on Kaiser Permanente Northwest (KPNW) data intended to document any cardiac events associated with Bavarian Nordic's two-dose JYNNEOS® vaccine.
Since May 2022, about 600,000 people have received one or more vaccine doses in the U.S.
And New York City began offering people second doses of JYNNEOS in September 2022.
Read More
